Synthetic peptide, and cosmetic composition or pharmaceutical composition and application thereof
US-2024352069-A1 · Oct 24, 2024 · US
US10377795B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10377795-B2 |
| Application number | US-201515113287-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 21, 2015 |
| Priority date | Jan 22, 2014 |
| Publication date | Aug 13, 2019 |
| Grant date | Aug 13, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A binding agent is capable of binding to rare earth materials such as rare earths and inorganic compounds thereof. A rare earth material-binding agent includes a peptide capable of binding to a rare earth material including a rare earth and a rare earth inorganic compound.
Opening claim text (preview).
The invention claimed is: 1. A method for producing a complex of a rare earth material-binding agent and a rare earth material, comprising: bringing the rare earth material-binding agent comprising a peptide capable of binding to the rare earth material into contact with the rare earth material to form the complex, wherein the rare earth material comprises at least one rare earth atom selected from the group consisting of lanthanum (La), lanthanum (La) ion, cerium (Ce), cerium (Ce) ion, neodymium (Nd), neodymium (Nd) ion, samarium (Sm), samarium (Sm) ion, gadolinium (Gd), gadolinium (Gd) ion, terbium (Tb), terbium (Tb) ion, dysprosium (Dy), dysprosium (Dy) ion, holmium (Ho), holmium (Ho) ion, erbium (Er), and erbium (Er) ion, and the peptide has an amino acid sequence represented by Leu-Trp-Gly-Asp/Glu-Val-Ser/Asn-Asp/Glu-Leu/Val-Asp/Glu-Phe/Leu-Leu. 2. The method according to claim 1 , wherein the peptide is a cyclic peptide. 3. The method according to claim 1 , wherein the rare earth material comprises dysprosium and a dysprosium ion, and the binding agent binds to the dysprosium ion and an oxide of dysprosium. 4. The method according to claim 1 , wherein the peptide has a label substance bound thereto. 5. The method according to claim 1 , wherein the rare earth atom is at least one rare earth ion selected from the group consisting of lanthanum (La) ion, cerium (Ce) ion, neodymium (Nd) ion, samarium (Sm) ion, gadolinium (Gd) ion, terbium (Tb) ion, dysprosium (Dy) ion, holmium (Ho) ion, and erbium (Er) ion. 6. The method according to claim 5 , wherein the complex is an inorganic compound comprising the at least one rare earth ion. 7. The method according to claim 5 , wherein the at least one rare earth ion is dysprosium (Dy) ion. 8. The method according to claim 6 , wherein the at least one rare earth ion is dysprosium (Dy) ion.
oxide or hydroxide being the only anion · CPC title
Nanometer sized, i.e. from 1-100 nanometer · CPC title
by XPS, EDX or EDAX data · CPC title
having 5 to 11 amino acids · CPC title
Obtaining rare earth metals · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.